CefoBio and Uzbekistan discussed regenerative medicine projects
Uzbekistan and South Korea's CefoBio discussed cell therapy, regenerative medicine, and the localization of bone tissue regeneration technologies.
CefoBio and Uzbekistan Discussed Regenerative Medicine Projects
Tashkent, Uzbekistan (UzDaily.uz) –
Uzbekistan and the South Korean company CefoBio held talks on expanding cooperation in cell therapy, regenerative medicine, and advanced biotechnology, according to the Agency for the Development of the Medical and Pharmaceutical Industry.
The meeting took place during a working visit by Agency Director Abdulla Azizov to the Republic of Korea. CefoBio CEO Park Hyun-seok also participated in the talks.
The parties reached preliminary agreements on joint research projects in collaboration with the Pharmaceutical Technical University (PTU). One of the key areas will be the development of bone tissue regeneration technologies.
Furthermore, the meeting participants agreed to jointly explore the prospects for localizing relevant technologies in Uzbekistan.
The parties also discussed the implementation of CefoBio's advanced biotechnological developments in Uzbekistan, the consolidation of research potential, and the development of next-generation medical technologies.
Cefobio specializes in the production of therapeutic drugs for bone tissue regeneration. The company operates a GMP-compliant center, which includes three independent production sites, as well as laboratories for virology, mycoplasma, sterility, and physicochemical analysis.